Xenon Pharmaceuticals Inc.·4

Jan 21, 5:04 PM ET

KENNEY CHRISTOPHER JOHN 4

4 · Xenon Pharmaceuticals Inc. · Filed Jan 21, 2022

Insider Transaction Report

Form 4
Period: 2022-01-21
KENNEY CHRISTOPHER JOHN
Chief Medical Officer
Transactions
  • Purchase

    Common Shares

    2022-01-21$28.81/sh+700$20,167700 total

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION